Mycophenolate mofetil and deflazacort combination in neuropsychiatric lupus: a decade of experience from a tertiary care teaching hospital in southern India

[1]  L. Trouw,et al.  Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus , 2016, Lupus.

[2]  G. Hunder,et al.  Mycophenolate mofetil in primary central nervous system vasculitis. , 2015, Seminars in arthritis and rheumatism.

[3]  S. Hamed,et al.  Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation , 2013, Rheumatology International.

[4]  I. Bruce,et al.  Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus , 2009, Annals of the rheumatic diseases.

[5]  Simone Appenzeller,et al.  Magnetic Resonance Imaging in the Evaluation of Central Nervous System Manifestations in Systemic Lupus Erythematosus , 2008, Clinical reviews in allergy & immunology.

[6]  X. Zhang,et al.  Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients , 2008, Lupus.

[7]  H. Jasper,et al.  Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients , 2007, Pediatric Nephrology.

[8]  P. Clark,et al.  Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus , 2005, Annals of the rheumatic diseases.

[9]  F. Jennekens,et al.  The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. , 2002, Rheumatology.

[10]  Caroline Gordon,et al.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.

[11]  L. Kahl,et al.  Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.

[12]  S. Kapoor,et al.  Prevalence of Systemic Lupus Erythematosus in India , 1993, Lupus.

[13]  M. Cassader,et al.  Deflazacort vs Prednisone: Effect on Blood Glucose Control in Insulin-Treated Diabetics , 1987 .

[14]  J. Hanly.  Neuropsychiatric lupus , 2005, Rheumatic Disease Clinics of North America.

[15]  B. Allolio,et al.  Comparison of the pharmacodynamic effects of deflazacort and prednisolone in healthy subjects , 1996, European Journal of Clinical Pharmacology.